Home LiteratureArticle Details
PMID: 9266969 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The transcriptional repressor ICER and cAMP-induced programmed cell death.

Oncogene ·Vol. 15 ·No. 7 ·1997-08-14 ·Pages 827-36

Ruchaud S, Seité P, Foulkes NS, Sassone-Corsi P, Lanotte M

Abstract

The cAMP pathway plays a central role in the response to hormonal signals for cell proliferation, differentiation and apoptosis. In IPC-81 leukaemia cells, activation of the cAMP pathway by prostaglandin E1 treatment, or other cAMP-elevating agents, induces apoptosis within 4-6 h. Inhibition of mRNA or protein synthesis during the first 2 h of cAMP induction protects cells from apoptosis, suggesting a requirement for early gene expression. cAMP-dependent protein kinase phosphorylates a class of nuclear factors and thereby regulates the transcription of a specific set of genes. Here we show that CREM (cAMP Responsive Element Modulator) expression is induced rapidly upon prostaglandin E1 treatment of IPC-81 cells. The induced transcripts correspond to the early product ICER (Inducible cAMP Early Repressor). ICER expression remains elevated until the burst of cell death. Protein synthesis inhibitors which prevent cAMP-induced apoptosis also block de novo ICER synthesis. Transfected IPC-81 cell lines, constitutively expressing high level of ICER are resistant to cAMP-induced cell death. In these transfected cells, cAMP fails to upregulate the ICER transcripts demonstrating that ICER exerts strongly its repressor function on CRE-containing genes. That an early expression of ICER blocks apoptosis, suggests that gene repression by endogenous ICER in IPC-81 is insufficient or occurs too late to protect cells against death. ICER transfected cells rescued from cAMP-induced apoptosis are growth arrested. It shows for the first time that CREM activation directly participates to the decision of the cell to die. ICER, by sequentially repressing distinct sets of CRE-containing genes could modulate cell fate.

MeSH Terms
Alprostadil/pharmacology Animals Apoptosis/drug effects,genetics Cyclic AMP/antagonists & inhibitors,physiology Cyclic AMP Response Element Modulator Cyclic AMP Response Element-Binding Protein/metabolism Cycloheximide/pharmacology DNA-Binding Proteins/antagonists & inhibitors,genetics,metabolism Gene Expression Regulation Leukemia, Myeloid/genetics,metabolism,pathology Protein Synthesis Inhibitors/pharmacology RNA, Messenger/metabolism Rats Repressor Proteins Transfection
Chemicals
Cyclic AMP Response Element-Binding Protein DNA-Binding Proteins Protein Synthesis Inhibitors RNA, Messenger Repressor Proteins Cyclic AMP Response Element Modulator Cycloheximide Cyclic AMP Alprostadil
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ruchaud S
INSERM U301, Centre G. Hayem, Hôpital St Louis, Paris, France.
Seité P
Foulkes N S
Sassone-Corsi P
Lanotte M
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
1997-08-14
Pages
827-36
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com